Pembrolizumab-Induced Lichen Planus in a Patient With Non-Small-Cell Lung Carcinoma (NSCLC) That Correlates to Therapeutic Response

Immune checkpoint inhibitors are increasingly being used in the treatment of various solid organ and hematologic malignancies. Dermatologic toxicities associated with programmed cell death protein-1 (PD-1) and programmed death ligand-1 (PD-L1) therapy have been widely reported in the literature. Lic...

Descripción completa

Detalles Bibliográficos
Autores principales: Sehbai, Aasim, Hamid, Muhammad A, Ibrahim, Zainab
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Dermatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9747249/
https://www.ncbi.nlm.nih.gov/pubmed/36523676
http://dx.doi.org/10.7759/cureus.31454

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9747249/
https://www.ncbi.nlm.nih.gov/pubmed/36523676
http://dx.doi.org/10.7759/cureus.31454

Ejemplares similares